ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Tivozanib or Bevacizumab Plus mFOLFOX6 in mCRC (Clinical Cancer Research) Friday October 14th 2016


100) TAK-264 in Advanced Gastrointestinal Malignancies (Clinical Cancer Research) Friday October 14th 2016


101) Differential Distant Recurrence Risk by BCI and RS (Clinical Cancer Research) Friday October 14th 2016


102) Genetics of Pituitary Tumors (Clinical Cancer Research) Friday October 14th 2016


103) Translational Innovation in PNETs (Clinical Cancer Research) Friday October 14th 2016


104) Thyroid Cancer (Clinical Cancer Research) Friday October 14th 2016


105) Pheochromocytoma and Metabolomics (Clinical Cancer Research) Friday October 14th 2016


106) Management of Adrenocortical Cancer (Clinical Cancer Research) Friday October 14th 2016


107) Endocrine Neoplasia (Clinical Cancer Research) Friday October 14th 2016


108) Endocrine Cancers: Defying the Paradigms (Clinical Cancer Research) Friday October 14th 2016


109) Role of Suppressive Cytokine IL35 in Disease (Clinical Cancer Research) Friday October 14th 2016


110) FDA Approval Summary: Palbociclib (Clinical Cancer Research) Friday October 14th 2016


111) Pancreatic Cysts (Clinical Cancer Research) Friday October 14th 2016


112) Multiparametric Genomic Assays for Breast Cancer (Clinical Cancer Research) Friday October 14th 2016


113) Retraction: Synergistic Interactions between Vorinostat and Sorafenib in Chronic Myelogenous Leukemia Cells Involve Mcl-1 and p21CIP1 Down-Regulation (Clinical Cancer Research) Wednesday October 5th 2016


114) FCGR, Cetuximab, and Colorectal Cancer Survival--Letter (Clinical Cancer Research) Wednesday October 5th 2016


115) FOXM1 and FOXQ1 Are Prognostic Biomarkers in Colorectal Cancer (Clinical Cancer Research) Wednesday October 5th 2016


116) Pancreatic Stellate Cells Regulate Lumican Secretion (Clinical Cancer Research) Wednesday October 5th 2016


117) BCAM in KRAS-Mutant Metastatic Colorectal Cancer (Clinical Cancer Research) Wednesday October 5th 2016


118) Immunotoxin Activity against B-ALL Depends on Exposure Time (Clinical Cancer Research) Wednesday October 5th 2016


119) Immunomodulatory Drugs Reactivate Lytic EBV (Clinical Cancer Research) Wednesday October 5th 2016


120) VAC14 SNP Predicts Docetaxel-Induced Neuropathy (Clinical Cancer Research) Wednesday October 5th 2016


121) Molecular Classification of NSCLC (Clinical Cancer Research) Wednesday October 5th 2016


122) Biomarkers in HCC Treated with Sorafenib Plus Erlotinib (Clinical Cancer Research) Wednesday October 5th 2016


123) Novel HER2 Mutations and HER2-Targeted Therapies (Clinical Cancer Research) Wednesday October 5th 2016


124) Surrogate Markers for Ipilimumab-Treated Patients (Clinical Cancer Research) Wednesday October 5th 2016


125) Resistant Mechanisms to AZD9291 and Rociletinib (Clinical Cancer Research) Wednesday October 5th 2016


126) Anti-CEA DNA Fusion Vaccination (Clinical Cancer Research) Wednesday October 5th 2016


127) DNA Damage in Normal Tissues during Lung Radiotherapy (Clinical Cancer Research) Wednesday October 5th 2016


128) Inotuzumab plus R-CVP for Relapsed/Refractory B-cell NHL (Clinical Cancer Research) Wednesday October 5th 2016


129) Temsirolimus for Newly Diagnosed Glioblastoma (Clinical Cancer Research) Wednesday October 5th 2016


130) Notch Inhibition in Glioma Patients (Clinical Cancer Research) Wednesday October 5th 2016


131) IMA950 Phase I Trial Final Results (Clinical Cancer Research) Wednesday October 5th 2016


132) Physical Activity and Cancer: A Precision Medicine Approach (Clinical Cancer Research) Wednesday October 5th 2016


133) Bystander and Abscopal Effects of Radiotherapy (Clinical Cancer Research) Wednesday October 5th 2016


134) The More Antigens the Merrier (Clinical Cancer Research) Wednesday October 5th 2016


135) AACR Cancer Progress Report 2016: Improving Lives Through Research (Clinical Cancer Research) Wednesday October 5th 2016


136) Correction: Novel Antitumor Effect of Estradiol in Athymic Mice Injected with a T47D Breast Cancer Cell Line Overexpressing Protein Kinase C Alpha (Clinical Cancer Research) Thursday September 15th 2016


137) High APOBEC3G Expression in TILs in Ovarian Cancer (Clinical Cancer Research) Thursday September 15th 2016


138) Characterize Subtypes of HPV-Positive Head and Neck Cancers (Clinical Cancer Research) Thursday September 15th 2016


139) PD-L1 and PD-1 Expression in Thymic Carcinoma (Clinical Cancer Research) Thursday September 15th 2016


140) Carfilzomib's Molecular Targets in CLL (Clinical Cancer Research) Thursday September 15th 2016


141) Peptide-Based Inhibition of ATF5 for Cancer Therapy (Clinical Cancer Research) Thursday September 15th 2016


142) Dual FASN and EGFR Blockade in TNBC (Clinical Cancer Research) Thursday September 15th 2016


143) RACGAP1 Is a Metastatic Driver in Uterine Carcinosarcoma (Clinical Cancer Research) Thursday September 15th 2016


144) Early Detection Biomarkers for Ovarian Cancer (Clinical Cancer Research) Thursday September 15th 2016


145) AR and AR-V7 RISH in Prostate Cancer (Clinical Cancer Research) Thursday September 15th 2016


146) PTK2/FAK and Radioresistance (Clinical Cancer Research) Thursday September 15th 2016


147) Targeted Dual-Modality Imaging in Renal Cell Carcinoma (Clinical Cancer Research) Thursday September 15th 2016


148) Molecular Characterization of Salivary Duct Carcinoma (Clinical Cancer Research) Thursday September 15th 2016


149) WRN Methylation Does Not Improve Irinotecan-Treated CRC Outcome (Clinical Cancer Research) Thursday September 15th 2016


150) Blood Test for Colorectal Cancer Detection (Clinical Cancer Research) Thursday September 15th 2016


151) Clinical Impact of Dual Block by pCR in HER2+ Breast Cancer (Clinical Cancer Research) Thursday September 15th 2016


152) PD-1 Pathway Blockade in EGFR-Mutant and ALK-Positive NSCLC (Clinical Cancer Research) Thursday September 15th 2016


153) AMG 780 in Patients with Advanced Solid Tumors (Clinical Cancer Research) Thursday September 15th 2016


154) Phase I Study of CUDC-427 (Clinical Cancer Research) Thursday September 15th 2016


155) Marizomib in Advanced Malignancies Including Multiple Myeloma (Clinical Cancer Research) Thursday September 15th 2016


156) Clinical Proteomics to Catalyze the Cancer Moonshot Program (Clinical Cancer Research) Thursday September 15th 2016


157) Safety Profile of Immune Checkpoint Antibodies (Clinical Cancer Research) Thursday September 15th 2016


158) FDA Approval: Uridine Triacetate for Fluorouracil Overdose (Clinical Cancer Research) Thursday September 15th 2016


159) EPIC Early Detection of Ovarian Cancer (Clinical Cancer Research) Thursday September 15th 2016


160) PD-1 Axis Inhibitors in EGFR- and ALK-Driven Lung Cancer (Clinical Cancer Research) Thursday September 15th 2016


161) Correction: Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy--DAFNE (GBG-70) (Clinical Cancer Research) Thursday September 1st 2016


162) Subclonal and Clonal Gene Mutations in CLL (Clinical Cancer Research) Thursday September 1st 2016


163) TGF{beta}2 in Breast Milk Exosomes (Clinical Cancer Research) Thursday September 1st 2016


164) Defining Castration-Resistant Prostate Cancer Stem Cells (Clinical Cancer Research) Thursday September 1st 2016


165) LOX and SNAI2 in Cancer (Clinical Cancer Research) Thursday September 1st 2016


166) Role of Extracellular Visfatin in Breast Cancer (Clinical Cancer Research) Thursday September 1st 2016


167) EPI Overcomes Resistance Mechanisms in CRPC (Clinical Cancer Research) Thursday September 1st 2016


168) Targeting Glycolysis for MYC-Driven Glioblastoma (Clinical Cancer Research) Thursday September 1st 2016


169) Bim Binding to Mcl-1 Causes Resistance to ABT-199 (Clinical Cancer Research) Thursday September 1st 2016


170) ADAM17 and Ionizing Radiation in NSCLC (Clinical Cancer Research) Thursday September 1st 2016


171) In Vivo Imaging of CEA TCB Activity (Clinical Cancer Research) Thursday September 1st 2016


172) Novel Gene-Modified Effector T Cells for Mogamulizumab (Clinical Cancer Research) Thursday September 1st 2016


173) Polyamine Antagonism in Neuroblastoma (Clinical Cancer Research) Thursday September 1st 2016


174) Recombinant HER2/neu-Expressing Listeria in Osteosarcoma (Clinical Cancer Research) Thursday September 1st 2016


175) Chaperonin Containing TCP-1 Protein Predicts Peptide Therapy (Clinical Cancer Research) Thursday September 1st 2016


176) Circulating Tumor DNA in Ewing Sarcoma (Clinical Cancer Research) Thursday September 1st 2016


177) GWAS in Multiple Myeloma Pharmacogenomics (Clinical Cancer Research) Thursday September 1st 2016


178) Targeting GRP78 in Drug-Resistant Myeloma (Clinical Cancer Research) Thursday September 1st 2016


179) Blocking IDO Rebound Immune Suppression Boosts Immunotherapy (Clinical Cancer Research) Thursday September 1st 2016


180) Cancer Prevention and Interception (Clinical Cancer Research) Thursday September 1st 2016


181) Mutational Landscape and Immunity in Cancer (Clinical Cancer Research) Thursday September 1st 2016


182) NF-{kappa}B in Cancer Therapeutics (Clinical Cancer Research) Thursday September 1st 2016


183) BOIN: A Simple, Well-Performing Bayesian Phase I Design (Clinical Cancer Research) Thursday September 1st 2016


184) New Strategies in Esophageal Cancer (Clinical Cancer Research) Thursday September 1st 2016


185) Targeting Androgen Receptor Aberrations (Clinical Cancer Research) Thursday September 1st 2016


186) Live Microscopy and Immunotherapy (Clinical Cancer Research) Thursday September 1st 2016


187) Correction: The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-{kappa}B Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells (Clinical Cancer Research) Monday August 15th 2016


188) Correction: Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas (Clinical Cancer Research) Monday August 15th 2016


189) Correction: Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver (Clinical Cancer Research) Monday August 15th 2016


190) DDGP versus SMILE in NK/T-Cell Lymphoma--Letter (Clinical Cancer Research) Monday August 15th 2016


191) BET Proteins Regulate Pancreatic Cancer Biology (Clinical Cancer Research) Monday August 15th 2016


192) VEGF Inhibits CD1d-Mediated NKT-Cell Activation (Clinical Cancer Research) Monday August 15th 2016


193) OX40+ Tregs in Cutaneous Squamous Cell Carcinoma (Clinical Cancer Research) Monday August 15th 2016


194) ALDH1A3 Affects Prognosis and Gemcitabine Resistance in CCA (Clinical Cancer Research) Monday August 15th 2016


195) Molecular Risk Assessment in Endometrial Cancer (Clinical Cancer Research) Monday August 15th 2016


196) Myeloma Cell Dynamics in Response to Treatment (Clinical Cancer Research) Monday August 15th 2016


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()